April 2022 – A major study elucidating the mechanism of action of the IBD-asset has been completed: Alma’s treatment facilitates mucosal healing without immune suppression
April 2022 – A major study elucidating the mechanism of action of the IBD-asset has been completed: Alma’s treatment facilitates mucosal healing without immune suppression